Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cyano Carboxylic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of xanthine oxidase inhibitors for gout treatment. Reliable pharmaceutical intermediates supplier offering cost reduction and scalable production capabilities.
Patent CN101863854A details a cost-effective synthesis of 2-(3-cyano-4-isobutoxy)phenyl-4-methyl-5-thiazolecarboxylic acid using bromination, offering high purity and scalability.
Novel synthesis route for cardiovascular intermediate. Optimized oxidation and cyanation steps ensure high purity and scalable production for global supply chains.
Patent CN103012311A details a novel etherification method using distilled isobutane bromide to eliminate n-propoxy impurities, ensuring superior API quality and supply reliability.
Advanced synthesis of PDE IV inhibitor intermediates via lithium bromide-mediated hydrolysis. Enhanced purity and streamlined manufacturing for pharmaceutical supply chains.
Patent CN110878064A reveals a breakthrough synthesis route for febuxostat impurities, boosting total yield from 0.2% to 43% via strategic intermediate sequencing.
Patent CN101497589B details a scalable synthesis for 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid, offering cost-effective manufacturing solutions.
Patent CN102241663B reveals a green aqueous synthesis for Strontium Ranelate. Achieve 90-95% yield with <0.3% impurities. Ideal for cost reduction in API manufacturing.
Novel non-toxic route for 2-(3-cyano-4-isobutoxy phenyl)-4-methyl-thiazole-5-carboxylic acid avoiding cyanides and corrosive acids.
Patent CN113773227A details a visible-light mediated method for epsilon-cyano carboxylic acids using CO2. Offers cost-effective pharma intermediate manufacturing.